1887
Surveillance report Open Access
Like 0
This item has no PDF Download

Abstract

A excepción de Israel, los datos representativos de Europa Occidental y Central indican niveles sistemáticamente bajos en las resistencias a la isoniazida (0-9,3%) o la rifampicina (0-2,1%) y en las multirresistencias (MDR) (0-2,1%) de los nuevos casos de

Loading

Article metrics loading...

/content/10.2807/esm.07.06.00423-es
2002-06-01
2017-11-20
http://instance.metastore.ingenta.com/content/10.2807/esm.07.06.00423-es
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/7/6/art00423-es.htm?itemId=/content/10.2807/esm.07.06.00423-es&mimeType=html&fmt=ahah
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error